Literature DB >> 16322481

Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.

Michael T Broman1, Panos Kouklis, Xiaopei Gao, Ramaswamy Ramchandran, Radu F Neamu, Richard D Minshall, Asrar B Malik.   

Abstract

The endothelial adherens junctions (AJs) consist of trans-oligomers of membrane spanning vascular endothelial (VE)-cadherin proteins, which bind beta-catenin through their cytoplasmic domain. beta-Catenin in turn binds alpha-catenin and connects the AJ complex with the actin cytoskeleton. We addressed the in vivo effects of loss of VE-cadherin interactions on lung vascular endothelial permeability and the role of specific Rho GTPase effectors in regulating the increase in permeability induced by AJ destabilization. We used cationic liposomes encapsulating the mutant of VE-cadherin lacking the extracellular domain (DeltaEXD) to interfere with AJ assembly in mouse lung endothelial cells. We observed that lung vascular permeability (quantified as microvessel filtration coefficient [K(f,c)]) was increased 5-fold in lungs expressing DeltaEXD. This did not occur to the same degree on expression of the VE-cadherin mutant, DeltaEXDDeltabeta, lacking the beta-catenin-binding site. The increased vascular permeability was the result of destabilization of VE-cadherin homotypic interaction induced by a shift in the binding of beta-catenin from wild-type VE-cadherin to the expressed DeltaEXD mutant. Because DeltaEXD expression in endothelial cells activated the Rho GTPase Cdc42, we addressed its role in the mechanism of increased endothelial permeability induced by AJ destabilization. Coexpression of dominant-negative Cdc42 (N17Cdc42) prevented the increase in K(f,c) induced by DeltaEXD. This was attributed to inhibition of the association of alpha-catenin with the DeltaEXD-beta-catenin complex. The results demonstrate that Cdc42 regulates AJ permeability by controlling the binding of alpha-catenin with beta-catenin and the consequent interaction of the VE-cadherin/catenin complex with the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322481     DOI: 10.1161/01.RES.0000198387.44395.e9

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  38 in total

Review 1.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

Review 2.  Regulatory pathways affecting vascular stabilization via VE-cadherin dynamics: insights from zebrafish (Danio rerio).

Authors:  Shahram Eisa-Beygi; R Loch Macdonald; Xiao-Yan Wen
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-16       Impact factor: 6.200

Review 3.  Mechanisms regulating endothelial permeability.

Authors:  Sukriti Sukriti; Mohammad Tauseef; Pascal Yazbeck; Dolly Mehta
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

Review 4.  Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.

Authors:  Yulia A Komarova; Kevin Kruse; Dolly Mehta; Asrar B Malik
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

Review 5.  Endothelial permeability and VE-cadherin: a wacky comradeship.

Authors:  Julie Gavard
Journal:  Cell Adh Migr       Date:  2013-12-05       Impact factor: 3.405

Review 6.  Cellular and molecular mechanisms underlying blood vessel lumen formation.

Authors:  Marta S Charpentier; Frank L Conlon
Journal:  Bioessays       Date:  2013-12-09       Impact factor: 4.345

7.  Cadherin selectivity filter regulates endothelial sieving properties.

Authors:  Sadiqa K Quadri; Li Sun; Mohammad Naimul Islam; Lawrence Shapiro; Jahar Bhattacharya
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Hepatocyte growth factor-induced Asef-IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier.

Authors:  Yufeng Tian; Grzegorz Gawlak; Alok S Shah; Katherine Higginbotham; Xinyong Tian; Yoshihiro Kawasaki; Tetsu Akiyama; David B Sacks; Anna A Birukova
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

9.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

10.  Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

Authors:  Yidan D Zhao; Hiroshi Ohkawara; Stephen M Vogel; Asrar B Malik; You-Yang Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.